BDR Pharmaceutical
-
BDR Pharma launches Zisavel capsules to treat invasive aspergillosis and mucormycosis
The product will be available in 100 mg capsules and is the first line of treatment for the aforementioned fungal…
Read More » -
BDR Pharma launches first generic to treat prostate cancer in India
The product will be available across India and shall be of 60 mg strength and available in two packs –…
Read More » -
BDR Pharma launches cancer drugs in India
Rucaparib is launched under the brand name BDPARIB in two strengths of 200 mg and 300 mg BDR Pharmaceutical has…
Read More »